# Apomorphine Pump in Early Stage of Parkinson's Disease (EARLY-PUMP)

> **NCT02864004** · PHASE3 · UNKNOWN · sponsor: **Rennes University Hospital** · enrollment: 134 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** Apomorphine
- **OTHER:** Best Medical Treatment

## Key facts

- **NCT ID:** NCT02864004
- **Lead sponsor:** Rennes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-03-03
- **Primary completion:** 2023-12-31
- **Final completion:** 2025-01-30
- **Target enrollment:** 134 (ACTUAL)
- **Last updated:** 2023-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02864004

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02864004, "Apomorphine Pump in Early Stage of Parkinson's Disease (EARLY-PUMP)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT02864004. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*